Oncolytic viruses
With its oncolytic viruses, Transgene attacks tumors on several fronts.
Oncolytics selectively multiply in cancer cells (a process called cell lysis) and indirectly trigger the activation of the immune system against the tumor.
Mechanism of action of oncolytic viruses
Transgene believes that oncolytic viruses, by integrating complimentary mechanisms of
action, can become an efficacious therapy for multiple cancers.
